Investors dashboard

We deliver strong returns for investors, by driving long-term growth through our bold vision, dynamic business model and innovative pipeline.

Events and presentations

Loading events...

Key financial data

€267M

Revenue for 2024

0 CHF -NaN (NaN%)

Volume: 0 14:31 CEST

more info

Media center

Loading news...

view all

Financial reports

Loading reports...

IR contact

Cosmo Pharmaceuticals NV

Riverside 2

49 Sir John Rogerson's Quay

Grand Canal Dock

Dublin, D02 KV60

Ireland

Be the first to know what’s new at Cosmo

stay informed